Exploring the Therapeutic Potential of Antidiabetic Drugs in Cardiac Arrhythmia Management: A Drug Target Mendelian Randomization Study
Open Access
- 4 December 2025
- journal article
- Published by Wiley in Journal of Arrhythmia
- Vol. 41 (6) , e70241
Abstract
Background: Cardiac arrhythmias pose a major health concern while the role of antidiabetic medications in cardiac arrhythmic risks is not fully understood. Method: We conducted a two‐sample Mendelian Randomization (MR) analysis using genetic instruments extracted from hemoglobin A1C (HbA1c) as proxies for antidiabetic drug targets to evaluate their causal relationship with five cardiac arrhythmias derived from the Finngen database. Summary‐data‐based Mendelian randomization (SMR) utilizing gene expression data from the eQTLgen consortium was further employed to assess the role of antidiabetic drug targets in cardiac arrhythmias from the gene expression perspective. Results: Three significant associations were identified. Sulfonylurea targets KCNJ11/ABCC8 were associated with a decreased incidence of paroxysmal tachycardia (OR: 0.69, 95% CI: 0.56, 0.86, P FDR = 0.022). Sodium‐glucose cotransporter 2 inhibitor (SGLT2i) target SLC5A2 was linked to a reduced risk of right bundle branch block (OR: 0.85, 95% CI: 0.77, 0.94, PFDR = 0.022), and thiazolidinediones (TZDs) targeting RXRB were associated with a lowered atrial fibrillation occurrence (OR: 0.88, 95% CI: 0.82, 0.94, P FDR = 0.019). No significant relationships were found between any antidiabetic drug targets and left bundle branch block or atrioventricular block. SMR analysis indicated that lowered expression of KCNJ11 was related to a decreased paroxysmal tachycardia risk (OR: 1.05, 95% CI: 1.01, 1.08, P SMR = 0.010), further confirming the role of KCNJ11 in paroxysmal tachycardia. Conclusion: Our findings suggest that several antidiabetic drug targets may have potential therapeutic applications in the management of cardiac arrhythmias.Keywords
Funding Information
- National Natural Science Foundation of China (81900229)
This publication has 49 references indexed in Scilit:
- Cardiac Arrhythmias: Diagnosis, Symptoms, and TreatmentsCell Biochemistry and Biophysics, 2015
- Mendelian Randomization Analysis With Multiple Genetic Variants Using Summarized DataGenetic Epidemiology, 2013
- Retinoid X receptors in macrophage biologyTrends in Endocrinology & Metabolism, 2013
- Efficient Design for Mendelian Randomization Studies: Subsample and 2-Sample Instrumental Variable EstimatorsAmerican Journal of Epidemiology, 2013
- KATPChannels and Cardiovascular DiseaseCirculation Research, 2013
- The retinoid X receptors and their ligandsBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2012
- Nuclear Hormone Retinoid X Receptor (RXR) Negatively Regulates the Glucose-Stimulated Insulin Secretion of Pancreatic β-CellsDiabetes, 2010
- Prevalence and Prognostic Significance of Exercise-Induced Right Bundle Branch BlockThe American Journal of Cardiology, 2010
- The cardiac sarcolemmal ATP-sensitive potassium channel as a novel target for anti-arrhythmic therapyPharmacology & Therapeutics, 2008
- Effects of Sulfonylurea Hypoglycemic Agents and Adenosine Triphosphate Dependent Potassium Channel Antagonists on Ventricular Arrhythmias in Patients with Decompensated Heart FailurePacing and Clinical Electrophysiology, 2003